echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Nomitoxantrone liposome in CSPC was approved for marketing, and Kunuoji's new traditional Chinese medicine icariin soft capsule was finally approved

    Nomitoxantrone liposome in CSPC was approved for marketing, and Kunuoji's new traditional Chinese medicine icariin soft capsule was finally approved

    • Last Update: 2022-02-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the information pending for the approval of the Food and Drug Administration, CSPC's mitoxantrone liposome has been approved for marketing



    Mitoxantrone is a traditional broad-spectrum chemotherapy drug used for leukemia, lymphoma, etc.



    The approved indication of CSPC's liposome formulation is for the treatment of relapsed or refractory peripheral T-cell lymphoma



    Kunnoki's Akraki (eprisingsoft capsule) has passed the paper, and finally approves the listing, indications are very interesting :


    It is used for unresectable hepatocellular carcinoma that is not suitable for or the patient refuses to receive standard treatment and has not received systemic systemic therapy before, and the patient's peripheral blood composite markers meet at least two of the following detection indicators: AFP≥400 ng/mL ; TNF-α<2.



    (Is this a first-line drug?)










    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.